BACKGROUND AND AIMS Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (MSM) has increased since 2000, though regional differences have been documented in recent years. We aimed to 1) estimate trends in HCV incidence among HIV-positive MSM, 2) assess the association between incidence and geographical region, age and HIV-related measurements and, 3) assess temporal changes in time from HIV seroconversion to HCV infection. METHODS We used data from MSM with well-estimated dates of HIV seroconversion from the CASCADE Collaboration (1990-2014). We allowed for smoothly varying trends in HCV incidence over calendar time using restricted cubic splines. We assessed the association of calendar year, age, CD4 coun...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
Background: Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of infect...
Background: Direct acting antivirals (DAA) cure 95% of patients infected with hepatitis C (HCV). Mod...
Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (...
Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (...
Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (...
BACKGROUND: Hepatitis C virus (HCV) infection has a growing impact on morbidity and mortality in pat...
Background: Hepatitis C virus (HCV) infection is a leading cause of hepatitis C, liver cancer, an...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground Despite the availability of highly effective direct-acting antivira...
International audienceBackground Despite the availability of highly effective direct-acting antivira...
BACKGROUND Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV)...
BACKGROUND Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV)...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
Background: Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of infect...
Background: Direct acting antivirals (DAA) cure 95% of patients infected with hepatitis C (HCV). Mod...
Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (...
Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (...
Background and Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have sex with men (...
BACKGROUND: Hepatitis C virus (HCV) infection has a growing impact on morbidity and mortality in pat...
Background: Hepatitis C virus (HCV) infection is a leading cause of hepatitis C, liver cancer, an...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground Despite the availability of highly effective direct-acting antivira...
International audienceBackground Despite the availability of highly effective direct-acting antivira...
BACKGROUND Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV)...
BACKGROUND Scale-up of direct-acting antiviral therapy is expected to abate hepatitis C virus (HCV)...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
International audienceBackground: Despite the availability of highly effective direct-acting antivir...
Background: Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of infect...
Background: Direct acting antivirals (DAA) cure 95% of patients infected with hepatitis C (HCV). Mod...